Insider trade

Officer sold ~$1.87M of COLL shares in the open market

Traded Mar 3, 2026 · Filed Mar 5, 2026

~$1.87M
Reported value · 46K sh @ $40.36: 75K
Holds after · shares reported: −45.3%
stock since the trade · S&P 500 +13.9%, $39.99 → $21.87 on Oct 5

Why it stands out

Collegium Pharmaceutical's & Chief Commercial Officer sold $1.87M of Collegium Pharmaceutical shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 3, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 5, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,873,557

Shares × reported transaction price

Timing vs results

5 days after results of Feb 26, 2026, 65 days before results of May 7, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	−7.5%	−1.5%	−6.0%
30 days	−12.6%	−2.0%	−10.6%
90 days	−12.3%	+12.6%	−24.9%
180 days	−34.8%	+13.8%	−48.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0001746251-26-000004
Filed / recorded: Mar 5, 2026, 9:29 PM UTC
Added to OQRO: Oct 6, 2026, 10:35 PM UTC
Parser: form4-xml-v2
Data quality: Verified: identifiers matched exactly
Issuer: COLLEGIUM PHARMACEUTICAL, INC
Issuer CIK: 1267565
Ticker: COLL
Reporting person: Scott Dreyer
Relationship: Officer
Officer title: EVP & Chief Commercial Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Mar 3, 2026
Transaction code: S
Shares / units: 46,417
Price per share: $40.36
Acquired / disposed: Disposed (D)
Shares owned after: 75,329
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.835 to $40.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Around the same time

8,840Shares · @ $35.72

6mo ago

Routine share withholding; mechanical by default.

More Official record

Officer sold ~$488K of Collegium Pharmaceutical, Inc.

Scheduled in advance7mo ago

Officer sold ~$228K of Collegium Pharmaceutical, Inc.

Scheduled in advance7mo ago